2002Linchuang pifuke zazhiRequires access

A comparison of response between mycophenolate mofetil and cyclophosphamide therapy for lupus nephritis

Donghua Liu

Open publisher page 1 citations

Abstract

To observe the efficacy and safety of mycophenolate mofetil(MMF )therapy for lupus nephritis,the patients with lu-pus nephritis diagnosed by kidney biopsy were divided into an experiment group treated with MMF and prednisone and a con-trol group treated with cyclophosphamide(CTX)and prednisone.Comparison of response to therapy was made between the two groups.It was found that though half of the patients of experiment group were resistant to CTX,there was no significant dif fer-ence in response to these two groups(P0.05),but the speed at which prednisone dosage was reduced in the experiment group was quicker than that of the control group(P0.01).It is suggested that the response to MMF therapy for lupus nephritis is better than CTX.

About this research paper

What this paper is about

To observe the efficacy and safety of mycophenolate mofetil(MMF )therapy for lupus nephritis,the patients with lu-pus nephritis diagnosed by kidney biopsy were divided into an experiment group treated with MMF and prednisone and a con-trol group treated with cyclophosphamide(CTX)and prednisone.Comparison of response to therapy was made between the two groups.It was found that though half of the patients of experiment group were resistant to CTX,there was no significant dif fer-ence in response to these two groups(P0.05),but the speed at which prednisone dosage was reduced in the experiment group was quicker than that of the control group(P0.01).It is suggested that the response to MMF therapy for lupus nephritis is better than CTX.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To observe the efficacy and safety of mycophenolate mofetil(MMF )therapy for lupus nephritis,the patients with lu-pus nephritis diagnosed by kidney biopsy were divided into an experiment group treated with MMF and prednisone and a con-trol group treated with cyclophosphamide(CTX)and prednisone.Comparison of response to therapy was made between the two groups.It was found that though half of the patients of experiment group were resistant to CTX,there was no significant dif fer-ence in response to these two groups(P0.05),but the speed at which prednisone dosage was reduced in the experiment group was quicker than that of the control group(P0.01).It is suggested that the response to MMF therapy for lupus nephritis is better than CTX.

Key concepts: Lupus nephritis, Prednisone, Mycophenolate, Cyclophosphamide, Medicine, Nephritis, Gastroenterology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A comparison of response between mycophenolate mofetil and cyclophosphamide therapy for lupus nephritis — Research Paper | ScholarLens